Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential

The Thomsen-Friedenreich (TF) antigen is expressed in a majority of human tumors due to aberrant glycosylation in cancer cells. There is strong evidence that humoral immune response to TF represents an effective mechanism for the elimination of cancer cells that express TF-positive glycoconjugates....

Full description

Bibliographic Details
Main Author: Oleg Kurtenkov
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2020/9747040
id doaj-cef6bd72207b4908a3c14bc1213f2d30
record_format Article
spelling doaj-cef6bd72207b4908a3c14bc1213f2d302020-11-25T01:47:49ZengHindawi LimitedBioMed Research International2314-61332314-61412020-01-01202010.1155/2020/97470409747040Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical PotentialOleg Kurtenkov0Department of Virology and Immunology, National Institute for Health Development, Hiiu 42, Tallinn 11619, EstoniaThe Thomsen-Friedenreich (TF) antigen is expressed in a majority of human tumors due to aberrant glycosylation in cancer cells. There is strong evidence that humoral immune response to TF represents an effective mechanism for the elimination of cancer cells that express TF-positive glycoconjugates. The presence of naturally occurring antibodies to tumor-associated TF and cancer-specific changes in their levels, isotype distribution and interrelation, avidity, and glycosylation profile make these Abs a convenient and ubiquitous marker for cancer diagnostics and prognostics. In this review, we attempt to summarize the latest data on the potential of TF-specific Abs for cancer diagnostics and prognostics.http://dx.doi.org/10.1155/2020/9747040
collection DOAJ
language English
format Article
sources DOAJ
author Oleg Kurtenkov
spellingShingle Oleg Kurtenkov
Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential
BioMed Research International
author_facet Oleg Kurtenkov
author_sort Oleg Kurtenkov
title Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential
title_short Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential
title_full Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential
title_fullStr Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential
title_full_unstemmed Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential
title_sort profiling of naturally occurring antibodies to the thomsen-friedenreich antigen in health and cancer: the diversity and clinical potential
publisher Hindawi Limited
series BioMed Research International
issn 2314-6133
2314-6141
publishDate 2020-01-01
description The Thomsen-Friedenreich (TF) antigen is expressed in a majority of human tumors due to aberrant glycosylation in cancer cells. There is strong evidence that humoral immune response to TF represents an effective mechanism for the elimination of cancer cells that express TF-positive glycoconjugates. The presence of naturally occurring antibodies to tumor-associated TF and cancer-specific changes in their levels, isotype distribution and interrelation, avidity, and glycosylation profile make these Abs a convenient and ubiquitous marker for cancer diagnostics and prognostics. In this review, we attempt to summarize the latest data on the potential of TF-specific Abs for cancer diagnostics and prognostics.
url http://dx.doi.org/10.1155/2020/9747040
work_keys_str_mv AT olegkurtenkov profilingofnaturallyoccurringantibodiestothethomsenfriedenreichantigeninhealthandcancerthediversityandclinicalpotential
_version_ 1715663166622400512